Navigation Links
Impulsivity, rewards and Ritalin: Monkey study shows tighter link

MADISON Even as the rate of diagnosis has reached 11 percent among American children aged 4 to 17, neuroscientists are still trying to understand attention deficit hyperactivity disorder (ADHD). One classic symptom is impulsivity the tendency to act before thinking.

Scientifically, impulsivity can appear as a choice for a small but immediate reward over a larger one that requires some delay. Choosing between present and future rewards is a fundamental need in schooling, says Luis Populin, associate professor of neuroscience at University of Wisconsin-Madison. "If you say to an impulsive child, 'Do your homework so you will get a good grade at the end of the quarter,' that has less appeal than 'Let's play baseball this afternoon instead of studying chemistry.'"

To study impulsive behavior, Populin and graduate student Abigail Zdrale Rajala selected two rhesus macaque monkeys with opposite behaviors. One was extremely calm, while the other was nervous, fidgety and impulsive. The monkeys were trained to stare at a dot on a screen and, when it went dark, to choose between two pictures placed to the side. Their choice of picture determined whether they got a small but immediate sip of water, or a larger sip, after a delay ranging up to 16 seconds.

As expected, the calm monkey, but not the impulsive one, quickly figured out that waiting would bring the sweeter result.

This willingness to take a smaller reward right away rather than a larger, delayed reward, called "temporal discounting," is a common feature of "combined type" ADHD, which specifically lists impulsivity among its diagnostic criteria, Populin says.

When the monkeys were given a dose of methylphenidate, the active ingredient of the common ADHD drug Ritalin, they chose the delayed reward more frequently. The impulsive monkey actually showed the same preference for delayed rewards as the unmedicated, calm monkey. However, identifiable differences in their performance mean that methylphenidate improved the condition, but did not eliminate it.

"There is no perfect animal model of ADHD," says Rajala, "but many studies are performed on rodents; this one was done in a non-human primate, which is much closer to humans." The Society for Neuroscience adjudged the paper valuable enough to support Rajala's travel to the conference in San Diego.

Methylphenidate changes the elimination of dopamine, a "reward" neurotransmitter that is elevated by drugs like cocaine and amphetamine. The result is that more dopamine remains in the brain, which is the most likely explanation for the altered reward processing in the medicated monkeys.

Some scientists have thought that temporal discounting in ADHD may result from cognitive processing, which relies on the highly evolved frontal cortex in the brain. The new results support an alternative, but less common, hypothesis: that temporal discounting is linked to the reward-processing mechanism, which is governed by more primitive parts of the brain.

By teasing apart one characteristic of ADHD, the study could help refine drug or behavioral treatments of a disability that has grown 16 percent more common just since 2007, Populin says.


Contact: Luis Populin
University of Wisconsin-Madison

Related medicine news :

1. Fieldtex Products Launches a New Wellness Rewards Service for Companies
2. Corporate Whistle Blower Center Now Urges Medical Device Insiders To Be A Whistleblower If They Can Prove The Device Maker Knew Of A Failure & Said Nothing=Huge Rewards
3. Hearing Partners of South Florida – Top Audiologist for Hearing Aids in Boynton Beach, FL – Announces New Referral Rewards Promotion
4. Announces New Rewards Program
5. Corporate Whistle Blower Center Urges ER Physicians Or Hospital Staff To Turn In Hospitals Admitting Patients For Medicare Fraud For Huge Whistleblower Rewards
6. Exceeds $1 Million of Snack Rewards Awarded to its Customers Through Unique Perks Program
7. SouthPark Hypnosis Offers Client Rewards Program
8. Corporate Whistle Blower Center Now Urges Employees of Any Type Of Private Contractor in Afghanistan or Iraq to Step Forward for Rewards if They Possess Proof of Fraud
9. Corporate Whistle Blower Center Now Urges Insiders to Step Forward if They Have Proof a Medical Device Maker Knew About Failures & Continued to Sell the Product-Rewards
10. Corporate Whistle Blower Center Now Urges Drug Maker Insiders To Call Them About Huge Rewards If They Can Prove Kickback, Price Fixing Schemes, Or Off Labeling Schemes
11. Corporate Whistle Blower Center Now Urges Physicians Or Drug Maker Insiders to Call Them About Whistleblower Rewards-If They Can Prove A Company Sells Defective Products
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday 27 ... NASDAQ to educate the personnel on spinal decompression therapy and offer his professional ... nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is conducive ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... rural West Tennessee to receive Gigabit Internet through a partnership this year with ... largest cities, Henderson is an attractive destination for entrepreneurs who want to build ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Florida Hospital Tampa is the ... of obesity in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, ... 18 years with a body mass index (BMI) of at least 40 to 45 kg, ...
(Date:12/1/2015)... ... ... Califia Farms , one of the fastest growing natural beverage companies ... in Beverage World Magazine’s Global Packaging Design Awards, taking home the Gold in the ... a 2015 U.S.A. Taste Champion in the American Masters of Taste Championships for its ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... WellStar Health System has signed a definitive ... Tenet Healthcare,s five metro Atlanta ... move following the conclusion of the due diligence period. ... and patient safety programs that have resulted in increased ... --> --> With ...
(Date:12/1/2015)... 2015  Eyeon Therapeutics has received a Notice ... based on a charged hydrophilic polymer developed at ... product has been shown to be safe and ... Mark Mitchnick , MD, CEO states, "This second ... polymers in conjunction with a therapeutic agent.  Nanoparticles ...
(Date:12/1/2015)... , Dec. 1, 2015 Pharma Tech Outlook ... Top 10 Clinical Data Management Solution Providers - 2015 ... distinguished panel comprising CEOs, CIOs, VCs, analysts, and the ... illustrious list of top 10 clinical data management solution ... on pages 14 and 36 respectively). ...
Breaking Medicine Technology: